Profile
William A.
Cavanagh worked as a Director at Haakon Ragde Foundation and as a Chief Scientific Officer at Sangretech Biomedical LLC.
He also worked at IsoRay Medical, Inc. as a Vice President-Research & Development from 2010 to 2016 and as a Chief Research & Development Officer at IsoRay, Inc. from 2019 to 2023.
He completed his undergraduate degree from the University of Portland.
Former positions of William Cavanagh
Companies | Position | End |
---|---|---|
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Chief Executive Officer | 2016-02-13 |
IsoRay Medical, Inc. /Old/ | Chief Tech/Sci/R&D Officer | 2016-03-02 |
Haakon Ragde Foundation | Director/Board Member | - |
Sangretech Biomedical LLC | Chief Tech/Sci/R&D Officer | - |
Training of William Cavanagh
University of Portland | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Health Technology |
Sangretech Biomedical LLC | |
Haakon Ragde Foundation | |
IsoRay Medical, Inc. /Old/ | Health Technology |
- Stock Market
- Insiders
- William Cavanagh